Uremic Pruritus, Treatment and Skin Care

Background: Pruritus is a condition affecting about 40% of patients with end stage chronic kidney disease (CKD ). Although the severity of chronic pruritus individually varies, it is in general severe in uremic pruritus (UP) and significantly affects the quality of life of patients. As the etiology...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the Turkish Academy of Dermatology 2017-06, Vol.11 (2)
Main Authors: Ünal, Emine, Kalkan, Göknur, Döner, Pınar
Format: Article
Language:English
Subjects:
Narcotics
Pruritus
Quality of life
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 2
container_start_page
container_title Journal of the Turkish Academy of Dermatology
container_volume 11
creator Ünal, Emine
Kalkan, Göknur
Döner, Pınar
description Background: Pruritus is a condition affecting about 40% of patients with end stage chronic kidney disease (CKD ). Although the severity of chronic pruritus individually varies, it is in general severe in uremic pruritus (UP) and significantly affects the quality of life of patients. As the etiology of UP is not clearly understood, there are many alternatives recommended for treatment. The aim of treatment is to reduce the severity of pruritus and to increase the quality of life of patients. Emollients, gabapentin and phototherapy are recommended as first line therapy in patients who are not suitable for kidney transplantation or who are at preparation stage. In patients refractory to these treatments, μ-opioid receptor antagonists such as naltrexone or κ-opioid receptor agonist such as nalfurafine can be preferred. Certain authors recommend adjuvant medicine and alternative treatments, however evidence level of these treatments is low. In patients who are refractory to all of these treatments, kidney transplantation as a precise and last treatment option in suitable patients. In this article, uremic pruritus and current treatment approaches are reviewed.
doi_str_mv 10.6003/jtad.17112r1
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2506768631</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2506768631</sourcerecordid><originalsourceid>FETCH-proquest_journals_25067686313</originalsourceid><addsrcrecordid>eNqNyrEKwjAUQNEgCBbt5gcEXBxsfS-xiZ1FcRSs4FaCjdBqU31J_l8HP8DpDucyNkfIFYBcd8E0OWpEQThiCUrQmSw31wlLve8AQJSi0LJI2PJCtm9v_ESR2hD9ildkTeitC9y4hp8freM7Q3bGxnfz9Db9dcoWh321O2YvGt7R-lB3QyT3pVoUoLTaKonyv-sD9w400w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2506768631</pqid></control><display><type>article</type><title>Uremic Pruritus, Treatment and Skin Care</title><source>Publicly Available Content (ProQuest)</source><creator>Ünal, Emine ; Kalkan, Göknur ; Döner, Pınar</creator><creatorcontrib>Ünal, Emine ; Kalkan, Göknur ; Döner, Pınar</creatorcontrib><description>Background: Pruritus is a condition affecting about 40% of patients with end stage chronic kidney disease (CKD ). Although the severity of chronic pruritus individually varies, it is in general severe in uremic pruritus (UP) and significantly affects the quality of life of patients. As the etiology of UP is not clearly understood, there are many alternatives recommended for treatment. The aim of treatment is to reduce the severity of pruritus and to increase the quality of life of patients. Emollients, gabapentin and phototherapy are recommended as first line therapy in patients who are not suitable for kidney transplantation or who are at preparation stage. In patients refractory to these treatments, μ-opioid receptor antagonists such as naltrexone or κ-opioid receptor agonist such as nalfurafine can be preferred. Certain authors recommend adjuvant medicine and alternative treatments, however evidence level of these treatments is low. In patients who are refractory to all of these treatments, kidney transplantation as a precise and last treatment option in suitable patients. In this article, uremic pruritus and current treatment approaches are reviewed.</description><identifier>EISSN: 1307-394X</identifier><identifier>DOI: 10.6003/jtad.17112r1</identifier><language>eng</language><publisher>Istanbul: Galenos Publishing House</publisher><subject>Narcotics ; Pruritus ; Quality of life</subject><ispartof>Journal of the Turkish Academy of Dermatology, 2017-06, Vol.11 (2)</ispartof><rights>2017. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2506768631/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2506768631?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,25732,27903,27904,36991,44569,74872</link.rule.ids></links><search><creatorcontrib>Ünal, Emine</creatorcontrib><creatorcontrib>Kalkan, Göknur</creatorcontrib><creatorcontrib>Döner, Pınar</creatorcontrib><title>Uremic Pruritus, Treatment and Skin Care</title><title>Journal of the Turkish Academy of Dermatology</title><description>Background: Pruritus is a condition affecting about 40% of patients with end stage chronic kidney disease (CKD ). Although the severity of chronic pruritus individually varies, it is in general severe in uremic pruritus (UP) and significantly affects the quality of life of patients. As the etiology of UP is not clearly understood, there are many alternatives recommended for treatment. The aim of treatment is to reduce the severity of pruritus and to increase the quality of life of patients. Emollients, gabapentin and phototherapy are recommended as first line therapy in patients who are not suitable for kidney transplantation or who are at preparation stage. In patients refractory to these treatments, μ-opioid receptor antagonists such as naltrexone or κ-opioid receptor agonist such as nalfurafine can be preferred. Certain authors recommend adjuvant medicine and alternative treatments, however evidence level of these treatments is low. In patients who are refractory to all of these treatments, kidney transplantation as a precise and last treatment option in suitable patients. In this article, uremic pruritus and current treatment approaches are reviewed.</description><subject>Narcotics</subject><subject>Pruritus</subject><subject>Quality of life</subject><issn>1307-394X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNqNyrEKwjAUQNEgCBbt5gcEXBxsfS-xiZ1FcRSs4FaCjdBqU31J_l8HP8DpDucyNkfIFYBcd8E0OWpEQThiCUrQmSw31wlLve8AQJSi0LJI2PJCtm9v_ESR2hD9ildkTeitC9y4hp8freM7Q3bGxnfz9Db9dcoWh321O2YvGt7R-lB3QyT3pVoUoLTaKonyv-sD9w400w</recordid><startdate>20170601</startdate><enddate>20170601</enddate><creator>Ünal, Emine</creator><creator>Kalkan, Göknur</creator><creator>Döner, Pınar</creator><general>Galenos Publishing House</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20170601</creationdate><title>Uremic Pruritus, Treatment and Skin Care</title><author>Ünal, Emine ; Kalkan, Göknur ; Döner, Pınar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_25067686313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Narcotics</topic><topic>Pruritus</topic><topic>Quality of life</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ünal, Emine</creatorcontrib><creatorcontrib>Kalkan, Göknur</creatorcontrib><creatorcontrib>Döner, Pınar</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Journal of the Turkish Academy of Dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ünal, Emine</au><au>Kalkan, Göknur</au><au>Döner, Pınar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Uremic Pruritus, Treatment and Skin Care</atitle><jtitle>Journal of the Turkish Academy of Dermatology</jtitle><date>2017-06-01</date><risdate>2017</risdate><volume>11</volume><issue>2</issue><eissn>1307-394X</eissn><abstract>Background: Pruritus is a condition affecting about 40% of patients with end stage chronic kidney disease (CKD ). Although the severity of chronic pruritus individually varies, it is in general severe in uremic pruritus (UP) and significantly affects the quality of life of patients. As the etiology of UP is not clearly understood, there are many alternatives recommended for treatment. The aim of treatment is to reduce the severity of pruritus and to increase the quality of life of patients. Emollients, gabapentin and phototherapy are recommended as first line therapy in patients who are not suitable for kidney transplantation or who are at preparation stage. In patients refractory to these treatments, μ-opioid receptor antagonists such as naltrexone or κ-opioid receptor agonist such as nalfurafine can be preferred. Certain authors recommend adjuvant medicine and alternative treatments, however evidence level of these treatments is low. In patients who are refractory to all of these treatments, kidney transplantation as a precise and last treatment option in suitable patients. In this article, uremic pruritus and current treatment approaches are reviewed.</abstract><cop>Istanbul</cop><pub>Galenos Publishing House</pub><doi>10.6003/jtad.17112r1</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier EISSN: 1307-394X
ispartof Journal of the Turkish Academy of Dermatology, 2017-06, Vol.11 (2)
issn 1307-394X
language eng
recordid cdi_proquest_journals_2506768631
source Publicly Available Content (ProQuest)
subjects Narcotics
Pruritus
Quality of life
title Uremic Pruritus, Treatment and Skin Care
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T03%3A10%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Uremic%20Pruritus,%20Treatment%20and%20Skin%20Care&rft.jtitle=Journal%20of%20the%20Turkish%20Academy%20of%20Dermatology&rft.au=%C3%9Cnal,%20Emine&rft.date=2017-06-01&rft.volume=11&rft.issue=2&rft.eissn=1307-394X&rft_id=info:doi/10.6003/jtad.17112r1&rft_dat=%3Cproquest%3E2506768631%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_journals_25067686313%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2506768631&rft_id=info:pmid/&rfr_iscdi=true